ED
SNBR

Exane Derivatives’s Sleep Number SNBR Stock Holding History

Exane Derivatives’s Portfolio SNBR Stock Details SNBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1
Closed -$35 – 635
2017
Q2 		$35 Hold
1
– – ﹤0.01% 598
2017
Q1 		$25 Hold
1
– – ﹤0.01% 543
2016
Q4 		$23 Hold
1
– – ﹤0.01% 609
2016
Q3 		$22 Hold
1
– – ﹤0.01% 599
2016
Q2 		$21 Sell
1
-2
-67% -$44 ﹤0.01% 524
2016
Q1 		$58 Sell
3
-38
-93% -$726 ﹤0.01% 546
2015
Q4 		$878 Hold
41
– – ﹤0.01% 404
2015
Q3 		$897 Sell
41
-1
-2% -$26 ﹤0.01% 436
2015
Q2 		$1.26K Sell
42
-2
-5% -$63 ﹤0.01% 433
2015
Q1 		$1.52K Sell
44
-31
-41% -$963 ﹤0.01% 431
2014
Q4 		$2.03K Buy
+75
New +$1.87K ﹤0.01% 459

Other funds holding SNBR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Exane Derivatives's SNBR Position: Q3 2017 in Review

Exane Derivatives sold out of Sleep Number (SNBR) in Q3 2017, closing a stake of 1 share — an estimated $35 sold.

Exane Derivatives first reported a position in SNBR in Q4 2014 and held it in 11 quarters. The position peaked at $2.03K in Q4 2014. 189 funds tracked by Wall St. Rank hold SNBR as of Q3 2017.

  • Exane Derivatives reported no remaining Sleep Number position as of Q3 2017 after selling out during the quarter.
  • Exane Derivatives sold 1 Sleep Number share in Q3 2017, an estimated $35.
  • Exane Derivatives first reported a position in Sleep Number in Q4 2014 and held it in 11 quarters.
  • Exane Derivatives's Sleep Number position peaked at $2.03K in Q4 2014.
  • 189 funds tracked by Wall St. Rank held Sleep Number as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.